Status: Phase 1
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
CROSS-LINKING AGENT Interleukin-18 cross-linking agent Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Pulmonary Disease, Chronic Obstructive 1 D029424 ClinicalTrials
Multiple Myeloma 1 D009101 ClinicalTrials
Still's Disease, Adult-Onset 1 D016706 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109604